Latest News

Follow-up MRI proposed as predictor of progression

 

REPORT FROM THE 25TH CONGRESS OF THE EUROPEAN COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS (ECTRIMS) – AMSTERDAM, THE NETHERLANDS, OCTOBER 19-22, 2011 – Two new studies suggest that follow-up MRI performed 6-12 months after starting treatment may help to identify poor responders at risk of disability progression.

Read More

Family history of epilepsy is reasonably accurate

 

Researchers at Columbia University report that the family histories provided by patients with epilepsy are reasonably accurate when it comes to siblings and children, but less so when it comes to parents (Ottman et al. Neurology 2011; 76: 390-396).

Read More

No evidence that NSAIDs lower PD risk

 

A case-control analysis of data from the Physicians’ Health Study reports that there is insufficient evidence that NSAID use lowers the risk of Parkinson’s disease (Driver et al. Br Med J 2011; epublished January 20, 2011; free full text at www.bmj.com/content/342/bmj.d198.long). The database included 22,007 physicians aged 40-84 years. Cases were matched by age and confounders (comorbidity, indicators for NSAID use).

Read More

TOPICS: